Should You Buy Enquest Plc & Ted Baker plc On Thursday?

Royston Wild runs the rule over headline makers Enquest Plc (LON: ENQ) and Ted Baker plc (LON: TED).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at two stocks making the news on Christmas Eve.

Oil play blasts higher

Shares in oil explorer Enquest (LSE: ENQ) have enjoyed a spectacular surge in the run-up to Christmas, the business last dealing 10.4% higher from Wednesday’s closing price.

Market appetite has been boosted by a slight recovery in the crude price in recent days. Although still subdued, the Brent benchmark has edged off the 11-year troughs of $36.04 per barrel struck at the start of the week and was last at $37.50.

On top of this, Enquest has been buoyed by comments from industry cartel OPEC that prices should return to $70 per barrel by the close of the decade due to the impact of escalating production costs.

But with diving oil prices continuing to confound claims that a price recovery is just around the corner, I believe that such projections should be viewed cautiously. Production from OPEC, the US and Russia looks set to keep surging, while Chinese economic deceleration continues to surprise to the downside.

Enquest saw revenues slip almost 12% between January and June, to $444m, thanks to the steady erosion in oil prices. So it comes as little surprise that the City expects earnings at Enquest to slip 61% for 2015, to 7 US cents per share. And the firm is expected to dip into the red in 2016 with losses of 3.6 cents per share.

Given Enquest’s wafer-thin balance sheet (net debt ballooned by more than a third year-on-year as of June, to $1.28bn) and with crude prices still rattling lower, I believe the firm remains a risk too far, even on a P/E rating of 4.2 times.

Retailer takes a hit

I’m far more optimistic concerning the growth outlook over at fashion brand Ted Baker (LSE: TED), despite the release of a pessimistic broker note from Jefferies.

Shares in the retailer slipped 1.6% on Christmas Eve after analysts advised late on Wednesday that the impact of mild weather, massive discounting in the US and economic cooling in Asia could hamper festive trading. Jeffries also cut its rating on Ted Baker to “hold” from “buy.”

Ted Baker has been one of the big retail winners in 2015, its stock price ascending 38% since the turn of January. And while Jefferies’ concerns may be well founded, I believe the retailer’s rampant global expansion drive should continue sending stock prices higher in 2016 and beyond.

Ted Baker’s splendid brand power has propelled earnings at double-digit percentages for many years now, and the City does not expect this trend to cease any time soon. Indeed, rises of 20% and 16% are chalked in for the years ending January 2016 and 2017 respectively.

A P/E rating of 30 times for next year may appear expensive from a conventional standpoint, but I fully expect this multiple to keep on toppling as profits head through the roof.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »